title: If roflumilast inhibits the innate immunity in the stable patient, what about infection?
authors.forename: Luis M
authors.initials: LM
authors.lastname: Blasco
mesh_terms: D000631:Aminopyridines / Q000008:administration & dosage* / Q000009:adverse effects*; D001549:Benzamides / Q000008:administration & dosage* / Q000009:adverse effects*; D003521:Cyclopropanes / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects*; D016867:Immunocompromised Host; D009894:Opportunistic Infections / Q000276:immunology*; D058988:Phosphodiesterase 4 Inhibitors / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D000631:Aminopyridines; D001549:Benzamides; D003521:Cyclopropanes; D058988:Phosphodiesterase 4 Inhibitors; C424423:Roflumilast